Biopolymeric nanocarrier: an auspicious system for oral delivery of insulin

References

• Abdallah MM, Fernández N, Matias AA, et al. Hyaluronic acid and chondroitin sulfate from marine and terrestrial sources: extraction and purification methods. Carbohydr Polym. 2020;243:116441.
   PubMed Web of Science ®Google Scholar
• Abdel-Moneim A, Ramadan H. Novel strategies to oral delivery of insulin: current progress of nanocarriers for diabetes management. Drug Dev Res. 2022;83(2):301–316.
   PubMed Web of Science ®Google Scholar
• Ahangarpour A, Oroojan AA, Khorsandi L, et al. Solid lipid nanoparticles of myricitrin have antioxidant and antidiabetic effects on streptozotocin-nicotinamide- induced diabetic model and myotube cell of male mouse. Oxid Med Cell Longev. 2018;2018:7496936.
   PubMed Web of Science ®Google Scholar
• Aibani N, Rai R, Patel P, et al. Chitosan nanoparticles at the biological interface: implications for drug delivery. Pharmaceutics. 2021;13(10):1686.
   PubMed Web of Science ®Google Scholar
• Alai MS, Lin WJ, Pingale SS. Application of polymeric nanoparticles and micelles in insulin oral delivery. J Food Drug Anal. 2015;23(3):351–358.
   PubMed Web of Science ®Google Scholar
• Al-Remawi M, Elsayed A, Maghrabi I, et al. Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system. Pharm Dev Technol. 2017;22(3):390–398.
   PubMed Web of Science ®Google Scholar
• Bhumkar DR, Joshi HM, Sastry M, et al. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res. 2007;24(8):1415–1426.
   PubMed Web of Science ®Google Scholar
• Boushra M, Tous S, Fetih G, et al. Methocel-lipid hybrid nanocarrier for efficient oral insulin delivery. J Pharm Sci. 2016;105(5):1733–1740.
   PubMed Web of Science ®Google Scholar
• Burova TV, Grinberg NV, Tur DR, et al. Ternary interpolyelectrolyte complexes insulin-poly(methylaminophosphazene)-dextran sulfate for oral delivery of insulin. Langmuir. 2013;29(7):2273–2281.
   PubMed Web of Science ®Google Scholar
• Chalasani KB, Russell-Jones GJ, Jain AK, et al. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J Control Release. 2007;122(2):141–150.
   PubMed Web of Science ®Google Scholar
• Chaturvedi K, Ganguly K, Kulkarni AR, et al. Oral insulin delivery using deoxycholic acid conjugated PEGylated polyhydroxybutyrate co-polymeric nanoparticles. Nanomedicine (Lond). 2015;10(10):1569–1583.
   PubMed Web of Science ®Google Scholar
• Chen T, Li S, Zhu W, et al. Self-assembly pH-sensitive chitosan/alginate coated polyelectrolyte complexes for oral delivery of insulin. J Microencapsul. 2019;36(1):96–107.
   PubMed Web of Science ®Google Scholar
• Chen MC, Sonaje K, Chen KJ, et al. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomaterials. 2011;32(36):9826–9838.
   PubMed Web of Science ®Google Scholar
• Chinnaiyan SK, Deivasigamani K, Gadela VR. Combined synergetic potential of metformin loaded pectin-chitosan biohybrids nanoparticle for NIDDM. Int J Biol Macromol. 2019;125:278–289.
   PubMed Web of Science ®Google Scholar
• Chuang EY, Nguyen GT, Su FY, et al. Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT. Biomaterials. 2013;34(32):7994–8001.
   PubMed Web of Science ®Google Scholar
• Clement S, Still JG, Kosutic G, et al. Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2. Diabetes Technol Ther. 2002;4(4):459–466.
   PubMedGoogle Scholar
• Compart J, Li X, Fettke J. Starch-A complex and undeciphered biopolymer. J Plant Physiol. 2021;258-259:153389.
   PubMed Web of Science ®Google Scholar
• Cui F, Zhang L, Zheng J, et al. A study of insulin-chitosan complex nanoparticles used for oral administration. J Drug Deliv Sci Technol. 2004;14(6):435–439. 2004
   Web of Science ®Google Scholar
• des Rieux A, Fievez V, Garinot M, et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116(1):1–27.
   PubMed Web of Science ®Google Scholar
• Elsayed A, Al Remawi M, Qinna N, et al. Formulation and characterization of an oily-based system for oral delivery of insulin. Eur J Pharm Biopharm. 2009;73(2):269–279.
   PubMed Web of Science ®Google Scholar
• Erel G, Kotmakci M, Akbaba H, et al. Nanoencapsulated chitosan nanoparticles in emulsion-based oral delivery system: in vitro and in vivo evaluation of insulin loaded formulation. J Drug Deliv Sci Techno. 2016;36:161–167.
   Web of Science ®Google Scholar
• Fonte P, Nogueira T, Gehm C, et al. Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin. Drug Deliv Transl Res. 2011;1(4):299–308.
   PubMed Web of Science ®Google Scholar
• Furda N, Wayzata M. Non-absorbable lipid binder. US Patent 4223023 1980. September 16.
   Google Scholar
• Goswami S, Bajpai J, Bajpai AK. Designing gelatin nanocarriers as a swellable system for controlled release of insulin: an in-Vitro kinetic study. J Macromol Sci A. 2009;47(2):119–130. 2009
   Web of Science ®Google Scholar
• Garcia MAVT, Garcia CF, Faraco AAG. Pharmaceutical and biomedical applications of native and modified starch: a review. Starch ‐ Stärke. 2020;72(7-8):1900270.
   Web of Science ®Google Scholar
• Grenha A, Remunan-Lopez C, Carvalho ELS, et al. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. Eur J Pharm Biopharm. 2008;69(1):83–93.
   PubMed Web of Science ®Google Scholar
• Grigoras AG. Polymer-lipid hybrid systems used as carriers for insulin delivery. Nanomedicine. 2017;13(8):2425–2437.
   PubMed Web of Science ®Google Scholar
• Haimhoffer Á, Rusznyák Á, Réti-Nagy K, et al. Cyclodextrins in drug delivery systems and their effects on biological barriers. Sci Pharm. 2019;87(4):33.doi:10.3390/scipharm87040033.
   Web of Science ®Google Scholar
• Halder A, Maiti S, Sa B. Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol-resin complex. Int J Pharm. 2005;302(1-2):84–94.
   PubMedGoogle Scholar
• Han L, Zhao Y, Yin L, et al. Insulin-Loaded pH-Sensitive hyaluronic acid nanoparticles enhance transcellular delivery. AAPS PharmSciTech. 2012;13(3):836–845.
   PubMed Web of Science ®Google Scholar
• He Z, Santos JL, Tian H, et al. Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin. Biomaterials. 2017;130:28–41.
   PubMed Web of Science ®Google Scholar
• Hu Q, Luo Y. Recent advances of polysaccharide based nanoparticles for oral insulin delivery. Int J Biol Macromol. 2018;120(Pt A):775–782.
   PubMedGoogle Scholar
• Huang D, Chen YS, Rupenthal ID. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery to the retina. Mol Pharm. 2017;14(2):533–545.
   PubMedGoogle Scholar
• Iacob AT, Lupascu FG, Apotrosoaei M, et al. Recent biomedical approaches for chitosan based materials as drug delivery nanocarriers. Pharmaceutics. 2021;13(4):587.
   PubMed Web of Science ®Google Scholar
• Idrees H, Zaidi SZJ, Sabir A, et al. A review of biodegradable natural Polymer-Based nanoparticles for drug delivery applications. Nanomaterials (Basel). 2020;10(10):1970.
   PubMedGoogle Scholar
• Iyer H, Khedkar A, Verma M. Oral insulin - a review of current status. Diabetes Obes Metab. 2010;12(3):179–185.
   PubMed Web of Science ®Google Scholar
• Jahangir MA, Khan R, Sarim Imam S. Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance. Artif Cells Nanomed Biotechnol. 2018;46(sup1):66–78.
   PubMed Web of Science ®Google Scholar
• Jhaveri J, Raichura Z, Khan T, et al. Chitosan Nanoparticles-Insight into properties, functionalization and applications in drug delivery and theranostics. Molecules. 2021;26(2):272.
   PubMed Web of Science ®Google Scholar
• Ji N, Hong Y, Gu Z, et al. Preparation and characterization of insulin-loaded zein/carboxymethylated short-chain amylose complex nanoparticlesAgric. J Agric Food Chem. 2017;65(40):8866–8874.
   PubMedGoogle Scholar
• Jin Y, Song Y, Zhu X, et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials. 2012;33(5):1573–1582.
   PubMed Web of Science ®Google Scholar
• Koland M, Anchan RB, Mukund SG, et al. Design and investigation of alginate coated solid lipid nanoparticles for oral insulin delivery. IJPER. 2021;55(2):383–394.
   Google Scholar
• Kumar A, Gupta S, Vasanth D. Polysaccharide-Based Nanocarriers for Oral Delivery of Insulin in Diabetes. In: Nayak A, Hasnain M. editors. Advanced Biopolymeric Systems for Drug Delivery. Advances in Material Research and Technology. Cham: Springer; 2020.
   Google Scholar
• Li H, Wang Y, Tang Q, et al. The protein corona and its effects on nanoparticle-based drug delivery systems. Acta Biomater. 2021;129:57–72.
   PubMed Web of Science ®Google Scholar
• Lin W, Garnett MC, Davies MC, et al. Preparation of surface-modified albumin nanospheres. Biomaterials. 1997;18(7):559–565.
   PubMed Web of Science ®Google Scholar
• Lin YH, Mi FL, Chen CT, et al. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules. 2007;8(1):146–152.
   PubMed Web of Science ®Google Scholar
• Liu D, Jiang G, Yu W, et al. Oral delivery of insulin using CaCO3 –based composite nanocarriers with hyaluronic acid coatings. Mater Lett. 2017;188:263–266.
   Web of Science ®Google Scholar
• Liu L, Zhou C, Xia X, et al. Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation. Int J Nanomed. 2016;11:761–769.
   PubMed Web of Science ®Google Scholar
• Lopes M, Shrestha N, Correia A, et al. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin. J Control Release. 2016;232:29–41.
   PubMed Web of Science ®Google Scholar
• Lopes MA, Abrahim BA, Seiça R, et al. Intestinal uptake of insulin nanoparticles: facts or myths? Curr Pharm Biotechnol. 2014;15(7):629–638.
   PubMed Web of Science ®Google Scholar
• Lopes MA, Abrahim-Vieira B, Oliveira C, et al. Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation. Int J Nanomed. 2015;10:5865–5880.
   PubMed Web of Science ®Google Scholar
• Loth F, Whistler RL. 1993. Industrial gums: polysaccharides and their derivatives in industrial gums: polysaccharides and their derivatives. 3rd edn, (James, N., BeMiller, J.N., eds), San Diego: Academic Press.
   Google Scholar
• Maestrelli F, Mura P, González-Rodríguez ML, et al. Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus. Int J Pharm. 2017;530(1-2):430–439.
   PubMedGoogle Scholar
• Mahkam M. Starch-based polymeric carriers for oral-insulin delivery. J Biomed Mater Res A. 2010;92(4):1392–1397.
   PubMedGoogle Scholar
• Maity S, Mukhopadhyay P, Kundu PP, et al. Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals: an in vitro and in vivo approach. Carbohydr Polym. 2017;170:124–132.
   PubMed Web of Science ®Google Scholar
• McClements DJ, Gumus CE. Natural emulsifiers—biosurfactants, phospholipids, biopolymers, and colloidal particles: molecular and physicochemical basis of functional performance. Adv Colloid Interface Sci. 2016;234:3–26.
   PubMed Web of Science ®Google Scholar
• Meneguin AB, Silvestre ALP, Sposito L, et al. The role of polysaccharides from natural resources to design oral insulin micro-and nanoparticles intended for the treatment of diabetes mellitus: a review. Carbohydr Polym. 2021;256:117504.
   PubMed Web of Science ®Google Scholar
• Morçöl T, Nagappan P, Nerenbaum L, et al. Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin. Int J Pharm. 2004;277(1-2):91–97.
   PubMedGoogle Scholar
• Mukhopadhyay P, Maity S, Mandal S, et al. Kundu PP. Preparation, characterization and in vivo evaluation of pH sensitive, safe quercetin-succinylated chitosan-alginate core-shell-corona nanoparticle for diabetes treatment. Carbohydr Polym. 2018;182:42–51.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Sarkar K, Chakraborty M, et al. Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model. Mater Sci Eng C Mater Biol Appl. 2013;33(1):376–382.
   PubMed Web of Science ®Google Scholar
• Musabayane CT, Munjeri O, Bwititi P, et al. Orally administered, insulin-loaded amidated pectin hydrogel beads sustain plasma concentrations of insulin in streptozotocin-diabetic rats. J Endocrinol. 2000;164(1):1–6.
   PubMed Web of Science ®Google Scholar
• Pan Y, Li YJ, Zhao HY, et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm. 2002;249(1-2):139–147.
   PubMed Web of Science ®Google Scholar
• Panigrahy SK, Bhatt R, Kumar A. Antioxidant potentials of successive solvent extracts from the unexplored hedhychium coronarium rhizome. J Food Sci Technol. 2017a;54(10):3297–3306.
   PubMed Web of Science ®Google Scholar
• Panigrahy SK, Bhatt R, Kumar A. Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes. J Drug Target. 2017b;25(2):93–101.
   PubMed Web of Science ®Google Scholar
• Panigrahy SK, Bhatt R, Kumar A. Targeting type II diabetes with plant terpenes: the new and promising antidiabetic therapeutics. Biologia. 2021;76(1):241–254.
   Web of Science ®Google Scholar
• Peng Q, Liu J, Zhang T, et al. Digestive enzyme corona formed in the gastrointestinal tract and its impact on epithelial cell uptake of nanoparticles. Biomacromolecules. 2019;20(4):1789–1797.
   PubMed Web of Science ®Google Scholar
• Peng Q, Mu HL. The potential of protein-nanomaterial interaction for advanced drug delivery. J Control Release. 2016;225:121–132.
   PubMed Web of Science ®Google Scholar
• Peng Q, Wei XQ, Yang Q, et al. Enhanced biostability of nanoparticle-based drug delivery systems by albumin corona. Nanomedicine (Lond). 2015;10(2):205–214.
   PubMed Web of Science ®Google Scholar
• Peng Q, Sun X, Gong T, et al. Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin. Acta Biomater. 2013;9(2):5063–5069.
   PubMed Web of Science ®Google Scholar
• Pérez LA, Hernández R, Alonso JM, et al. Hyaluronic acid hydrogels crosslinked in physiological conditions: synthesis and biomedical applications. Biomedicines. 2021;9(9):1113.
   PubMed Web of Science ®Google Scholar
• Pérez-García L, Goñi-Iriarte MJ, García-Mouriz M. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes. Endocrinol Nutr. 2015;62(7):331–337.
   PubMedGoogle Scholar
• Plapied L, Duhem N, des Rieux A, et al. Fate of polymeric nanocarriers for oral drug delivery. Curr Opin Colloid Interface Sci. 2011;16(3):228–237.
   Web of Science ®Google Scholar
• Prakash P, Lee WH, Loo CY, et al. Advances in polyhydroxyalkanoate nanocarriers for effective drug delivery: an overview and challenges. Nanomaterials. 2022;12(1):175.
   Web of Science ®Google Scholar
• Ramadas M, Paul W, Dileep KJ, et al. Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats. J Microencapsul. 2000;17(4):405–411.
   PubMed Web of Science ®Google Scholar
• Rambaran TF. Nanopolyphenols: a review of their encapsulation and anti-diabetic effects. SN Appl Sci. 2020;2(8):1335.
   Web of Science ®Google Scholar
• Rani R, Dahiya S, Dhingra D, et al. Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic rats. Eur J Pharm Sci. 2017;106:220–230.
   PubMed Web of Science ®Google Scholar
• Rasmussen SE, Frederiksen H, Struntze Krogholm K, et al. Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol Nutr Food Res. 2005;49(2):159–174.
   PubMed Web of Science ®Google Scholar
• Reddy M, Ponnamma D, Choudhary R, et al. A comparative review of natural and synthetic biopolymer composite scaffolds. Polymers. 2021;13(7):1105.
   PubMed Web of Science ®Google Scholar
• Reis CP, Ribeiro AJ, Houng S, et al. Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity. Eur J Pharm Sci. 2007;30(5):392–397.
   PubMed Web of Science ®Google Scholar
• Robin AL, Sankhla D. European legislative framework controlling the use of food additives. Essential Guide Food Additives. London: Royal Society of Chemistry; 2013. p. 44–62.
   Google Scholar
• Roger E, Lagarce F, Garcion E, et al. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine (Lond). 2010;5(2):287–306.
   PubMed Web of Science ®Google Scholar
• Sajeesh S, Sharma CP. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int J Pharm. 2006;325(1–2):147–154.
   PubMed Web of Science ®Google Scholar
• Salamat-Miller N, Johnston TP. Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium. Int J Pharm. 2005;294(1–2):201–216.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Das D, Dutta P, et al. Chitosan: a promising therapeutic agent and effective drug delivery system in managing diabetes mellitus. Carbohydr Polym. 2020;247:116594.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ferreira D, Veiga F, et al. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr. Polym. 2006;66(1):1–7.
   Web of Science ®Google Scholar
• Sarmento B, Martins S, Ferreira D, et al. Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomed. 2007a;2(4):743–749.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Martins S, Ribeiro A, et al. Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers. Int J Pept Res Ther. 2006;12(2):131–138.
   Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, et al. Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules. 2007b;8(10):3054–3060.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, et al. Development and characterization of new insulin containing polysaccharide nanoparticles. Colloids Surf B Biointerfaces. 2006;53(2):193–202.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, et al. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res. 2007;24(12):2198–2206.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro AJ, Veiga F, et al. Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation. J Nanosci Nanotechnol. 2007;7(8):2833–2841.
   PubMed Web of Science ®Google Scholar
• Schipper NG, Vârum KM, Stenberg P, et al. Chitosans as absorption enhancers of poorly absorbable drugs. 3: influence of mucus on absorption enhancement. Eur J Pharm Sci. 1999;8(4):335–343.
   PubMed Web of Science ®Google Scholar
• Schöttler S, Landfester K, Mailänder V. Controlling the stealth effect of nanocarriers through understanding the protein corona. Angew Chem Int Ed Engl. 2016;55(31):8806–8815.
   PubMed Web of Science ®Google Scholar
• Seyam S, Nordin NA, Alfatama M. Recent progress of chitosan and chitosan Derivatives-Based nanoparticles: pharmaceutical perspectives of oral insulin delivery. Pharmaceuticals (Basel). 2020;13(10):307.
   Google Scholar
• Shah RB, Patel M, Maahs DM, et al. Insulin delivery methods: past, present and future. Int J Pharm Investig. 2016;6(1):1–9.
   PubMed Web of Science ®Google Scholar
• Sharma G, Sharma AR, Nam JS, et al. Nanoparticle based insulin delivery system: the next generation efficient therapy for type 1 diabetes. J Nanobiotechnol. 2015;13:74.
   PubMed Web of Science ®Google Scholar
• Sonaje K, Lin YH, Juang JH, et al. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials. 2009;30(12):2329–2339.
   PubMed Web of Science ®Google Scholar
• Sonia TA, Sharma CP. An overview of natural polymers for oral insulin delivery. Drug Discov Today. 2012;17(13-14):784–792.
   PubMed Web of Science ®Google Scholar
• Souquet JM, Cheynier V, Brossaud F, et al. Polymeric proanthocyanidins from grape skins. Phytochem. 1996;43(2):509–512.
   Web of Science ®Google Scholar
• Sun Q, Li G, Dai L, et al. Green preparation and characterisation of waxy maize starch nanoparticles through enzymolysis and recrystallisation. Food Chem. 2014;162:223–228.
   PubMed Web of Science ®Google Scholar
• Sundar S, Kundu J, Kundu SC. Biopolymeric nanoparticles. Sci Technol Adv Mater. 2010;11(1):014104.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Niwa T, et al. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res. 1996;13(6):896–901.
   PubMed Web of Science ®Google Scholar
• Tiyaboonchai W, Woiszwillo J, Sims RC, et al. Insulin containing polyethylenimine-dextran sulfate nanoparticles. Int J Pharm. 2003;255(1-2):139–151.
   PubMedGoogle Scholar
• Verma ML, Dhanya BS, Rani V, et al. Carbohydrate and protein based biopolymeric nanoparticles: current status and biotechnological applications. Int J Biol Macromol. 2020;154:390–412.
   PubMed Web of Science ®Google Scholar
• Wakaskar RR. Types of Nanocarriers - Formulation methods and applications. J Bioequiv. 2017;9(3):10000e10077.
   Google Scholar
• Wang AH, Yang TT, Fan WW, et al. Protein corona liposomes achieve efficient oral insulin delivery by overcoming mucus and epithelial barriers. Adv Healthcare Mater. 2019;8(12):1801123.
   Web of Science ®Google Scholar
• Wee S, Gombotz WR. Protein release from alginate matrices. Adv Drug Deliv Rev. 1998;31(3):267–285.
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Neufeld RJ, Veiga F, et al. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles. Eur J Pharm Sci. 2010;41(3-4):556–563.
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Veiga F, Ribeiro A, et al. Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin. Eur J Pharm Biopharm. 2009;73(1):25–33.
   PubMed Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment. J Control Release. 2017;264:247–275.
   PubMed Web of Science ®Google Scholar
• Wong CY, Martinez J, Dass CR. Oral delivery of insulin for treatment of diabetes: status, challenges and opportunities. J Pharm Pharmacol. 2016;68(9):1093–1108.
   PubMed Web of Science ®Google Scholar
• Wu ZH, Ping QN, Wei Y, et al. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice. Acta Pharmacol Sin. 2004;25(7):966–972.
   PubMed Web of Science ®Google Scholar
• Wüpper S, Lüersen K, Rimbach G. Cyclodextrins, natural compounds, and plant Bioactives-A nutritional perspective. Biomolecules. 2021;11(3):401.
   PubMed Web of Science ®Google Scholar
• Xie J, Li A, Li J. Advances in pH-Sensitive polymers for smart insulin delivery. Macromol Rapid Commun. 2017;38(23):1700413.
   Web of Science ®Google Scholar
• Yang JS, Xie YJ, He W. Research progress on chemical modification of alginate: a review. Carbohydr Polym. 2011;84(1):33–39.
   Web of Science ®Google Scholar
• Yin L, Ding J, He C, et al. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials. 2009;30(29):5691–5700.
   PubMed Web of Science ®Google Scholar
• Yu M, Ji N, Wang Y, et al. Starch-based nanoparticles: stimuli responsiveness, toxicity, and interactions with food components. Compr Rev Food Sci Food Saf. 2021;20(1):1075–1100.
   PubMed Web of Science ®Google Scholar
• Zhang T, Tang JZ, Fei X, et al. Can nanoparticles and nano‒protein interactions bring a bright future for insulin delivery? Acta Pharm Sin B. 2021;11(3):651–667.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhu G, Lu B, et al. Protein corona formed in the gastrointestinal tract and its impacts on oral delivery of nanoparticles. Med Res Rev. 2021;41(3):1835–1816.
   Web of Science ®Google Scholar
• Zhang N, Li J, Jiang W, et al. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles. Int J Pharm. 2010;393(1-2):212–218.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Chen Z, Paul PK, et al. Oral delivery of proteins and peptides: challenges, status quo and future perspectives. Acta Pharm Sin B. 2021;11(8):2416–2448.
   PubMed Web of Science ®Google Scholar
• Zion TC, Tsang HH, Ying JY. 2003. Glucose-sensitive nanoparticles for controlled insulin delivery.
   Google Scholar